CD69 and tuberculosis: Correlation analyses revealed that Vδ2 expression of the CD69 activation marker 12 weeks after IV BCG was associated with a better TB outcome, specifically the total gross pathology score and lung lesion count (p = 0.022, r = −0.928, and p = 0.033, r = −0.886, respectively).